首页> 外文OA文献 >Low Mutational Burden of Eight Genes Involved in the MAPK/ERK, PI3K/AKT, and GNAQ/11 Pathways in Female Genital Tract Primary Melanomas
【2h】

Low Mutational Burden of Eight Genes Involved in the MAPK/ERK, PI3K/AKT, and GNAQ/11 Pathways in Female Genital Tract Primary Melanomas

机译:八个基因的低突变负担参与Mapk / Erk,Pi3k / Akt,和女性生殖道原发性黑色素瘤中的GNAQ / 11途径

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Mucosal melanomas exhibit discrete genetic features compared to cutaneous melanoma. Limited studies on gynecological melanomas revealed significant heterogeneity and low mutational burden. To gain further insight into their genetics and DNA repair efficiency, we systematically investigated the status of eight genes whose products are critically involved in the MAPK/ERK, PI3K/AKT, and GNAQ/11 pathways, including BRAF, NRAS, HRAS, KRAS, c-KIT, PI3K, GNAQ, and GNA11, in a series of 16 primary gynecological melanomas, covering all anatomical locations, ranging from stages I to III. Analysis either by real-time PCR coupled with fluorescence melting curve analysis or by PCR followed by direct sequencing, along with studies for DNA mismatch repair status using immunohistochemistry, disclosed that 15 out of the 16 cases displayed wild-type genotypes, with a single case of vulvar primary melanoma, harboring the activating mutation BRAFV600E. Investigations on whether this could reflect partly an efficient mismatch repair (MMR) mechanism were confirmed by normal expression of hMLH1 and hMSH2, suggesting that the lack of mutations could be explained by the operation of alternative pathogenetic mechanisms modulating downstream effectors of the signaling pathways. Our data suggest the presence of additional genetic components and provide the impetus for systematic approaches to reveal these yet unidentified genetic parameters.
机译:与皮肤黑色素瘤相比,粘膜黑素瘤表现出离散的遗传特征。妇科黑素瘤的有限研究显示出显着的异质性和低突变负担。为了进一步了解他们的遗传和DNA修复效率,我们系统地研究了八个基因的地位,其产品批判性地参与MAPK / ERK,PI3K / AKT和GNAQ / 11途径,包括BRAF,NRAS,HRAS,KRA, C-KIT,PI3K,GNAQ和GNA11,在一系列16个主要妇科黑色素组中,覆盖所有解剖位置,从阶段I到III。通过实时PCR与荧光熔化曲线分析或通过PCR进行分析,然后通过直接测序,以及使用免疫组织化学的DNA失配修复状态的研究,公开了16例中的15例出现野生型基因型,具有单个案例外阴初级黑色素瘤,含有激活突变BRAFV600E。通过HMLH1和HMSH2的正常表达证实了对这是否可以反映的研究可以参与其中的有效不匹配修复(MMR)机制,表明可以通过调节信号传导途径的下游效应器的替代致病机制的操作来解释缺乏突变。我们的数据表明存在额外的遗传成分,并为系统方法提供推动,以揭示这些尚未认出的遗传参数。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号